HopeStage
Back to all studies
CompletedNCT01338298

Aripiprazole for High Prolactin Levels in Women With Schizophrenia

About this titleRead the official source — NCT01338298
Medication studyAges 18–50United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 50 years.

Listed locations
CatonsvilleSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: January 2011
Recruitment status
Completed
Enrollment listed in the registry
60
Sponsor
University of Maryland, Baltimore
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 50 Years
Official registry ID
NCT01338298
Official title
Show the full official title

Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Catonsville

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Maryland, Baltimore, a university.

Did this study involve medication?

Yes. The study involved medication, including Aripiprazole and Placebo.

Who was this study for?

Listed age limits: 18 years to 50 years.

Want to explore more studies?

Explore studies